Abstract:Introduction: Parkinson's disease (PD) is the second most common neurodegenerative disorder, increasing both in terms of prevalence and incidence. To date, only symptomatic treatment is available, highlighting the need to increase knowledge on disease etiology in order to develop new therapeutic strategies. Hemizygosity for the gene Engrailed-1 ( En1 ), encoding a conserved transcription factor essential for the programming, survival, and maintenance of midbrain dopaminergic neurons, leads to progressive nigrostriatal degeneration, motor impairment and depressive-like behavior in SwissOF1 (OF1 -En1 +/− ). The neurodegenerative phenotype is, however, absent in C57Bl/6j (C57 -En1 +/− ) mice. En1 +/− mice are thus highly relevant tools to identify genetic factors underlying PD susceptibility. Methods: Transcriptome profiles were defined by RNAseq in microdissected substantia nigra from 1-week old OF1, OF1- En1 +/− , C57 and C57- En1 +/− male mice. Differentially expressed genes (DEGs) were analyzed for functional enrichment. Neurodegeneration was assessed in 4- and 16-week old mice by histology. Results: Nigrostriatal neurodegeneration was manifested in OF1- En1 +/− mice by increased dopaminergic striatal axonal swellings from 4 to 16 weeks and decreased number of dopaminergic neurons in the SNpc at 16 weeks compared to OF1. In contrast, C57- En1 +/− mice had no significant increase in axonal swellings or cell loss in SNpc at 16 weeks. Transcriptomic analyses identified 198 DEGs between OF1- En1 +/− and OF1 mice but only 52 DEGs between C57- En1 +/− and C57 mice. Enrichment analysis of DEGs revealed that the neuroprotective phenotype of C57- En1 +/− mice was associated with a higher expression of oxidative phosphorylation-related genes compared to both C57 and OF1- En1 +/− mice. Discussion: Our results suggest that increased expression of genes encoding mitochondrial proteins before the onset of neurodegeneration is associated with increased resistance to PD-like nigrostriatal neurodegeneration. This highlights the importance of genetic background in PD models, how different strains can be used to model clinical and sub-clinical pathologies and provides insights to gene expression mechanisms associated with PD susceptibility and progression.

Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation

A WNT1-regulated Developmental Gene Cascade Prevents Dopaminergic Neurodegeneration in Adult En1(+/-) Mice.

Nigral transcriptomic profiles in Engrailed-1 hemizygous mouse models of Parkinson's disease reveal upregulation of oxidative phosphorylation-related genes associated with delayed dopaminergic neurodegeneration

Enhanced De Novo Neurogenesis And Dopaininergic Neurogenesis In The Substantia Nigra Of 1-Methyl-4-Phyenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson'S Disease-Like Mice

Heterozygous loss of Engrailed-1 and α-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence

Parkin Mutation Decreases Neurite Complexity and Maturation in Neurons Derived from Human Fibroblasts

Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease

Expression Changes of Transcription Factor EN1 in the Midbrain of Mice Model of Parkinson's Disease

Primary Cilia in Parkinson’s Disease: Summative Roles in Signaling Pathways, Genes, Defective Mitochondrial Function, and Substantia Nigra Dopaminergic Neurons

Cenpj regulates cilia disassembly and neurogenesis in the developing mouse cortex.

Primary cilia in Parkinson's disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons

Developmental deficits and early signs of neurodegeneration revealed by PD patient derived dopamine neurons

PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons

Depletion of Canonical Wnt Signaling Components Has a Neuroprotective Effect on Midbrain Dopaminergic Neurons in an MPTP-induced Mouse Model of Parkinson’s Disease

Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease

In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition

Ablation of Mitochondrial RCC1-L Induces Nigral Dopaminergic Neurodegeneration and Parkinsonian-like Motor Symptoms

Functional implications of NHR-210 enrichment in C. elegans cephalic sheath glia: insights into metabolic and mitochondrial disruptions in Parkinson's disease models

Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations

Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson's disease

Downregulation of CHCHD2 may Contribute to Parkinson's Disease by Reducing Expression of NFE2L2 and RQCD1